You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cardiac repolarization

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiac Repolarization Trial in Melbourne (Placebo, Moxifloxacin (positive control), Milademetan)

Not yet recruiting
  • Cardiac Repolarization
  • Placebo
  • +2 more
  • Melbourne, Victoria, Australia
    Nucleus Network Melbourne
Mar 6, 2023

Thoracic Paravertebral Block on Cardiac Repolarization

Enrolling by invitation
  • Paravertebral Block
  • QT Interval
  • Paravertebral block (ropivacaine) left
  • Paravertebral block (ropivacaine) right
  • Gdańsk, Poland
    Medical University of Gdańsk - Departament of Anesthesiology and
Apr 20, 2023

Healthy Volunteer Study Trial in Québec (Bemnifosbuvir (BEM), Placebo, Moxifloxacin)

Completed
  • Healthy Volunteer Study
  • Bemnifosbuvir (BEM)
  • +2 more
  • Québec, Montreal, Quebec, Canada
    Atea Study Site
Jun 14, 2023

QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)

Recruiting
  • QT/QTc
  • Ecopipam Hydrochloride
  • +2 more
  • Austin, Texas
    PPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023

Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib

Active, not recruiting
  • Healthy Subject
  • Orelabrutinib and placebo (orelabrutinib tablet simulator)
  • +3 more
  • Beijing, China
    Beijing GoBroad Boren Hospital
Dec 19, 2022

Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)

Recruiting
  • Non-alcoholic Steatohepatitis
  • Berlin, Germany
    Research Site
Jan 16, 2023

QTc Interval Trial in Overland Park (Psilocybin, Moxifloxacin, Micro-Crystalline Cellulose)

Recruiting
  • QTc Interval
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc
Jul 26, 2022

Normal Healthy Subjects Trial (Eravacyline, Moxifloxacin, and )

Completed
  • Normal Healthy Subjects
  • Eravacyline, Moxifloxacin, and placebo
  • (no location specified)
Dec 16, 2021

Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)

Recruiting
  • Healthy
  • Rodatristat Ethyl
  • +3 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Jul 5, 2023

Cardiac Repolarization in Healthy Subjects Trial in Tempe (TD-4208 175 mcg, TD-4208 700 mcg, Placebo for TD-4208)

Completed
  • Cardiac Repolarization in Healthy Subjects
  • TD-4208 175 mcg
  • +3 more
  • Tempe, Arizona
    Celerion
Feb 22, 2022

Healthy Trial in Springfield (Relacorilant, Placebo to relacorilant, Moxifloxacin)

Completed
  • Healthy
  • Springfield, Missouri
    Single Site
Sep 10, 2021

Development ofArtificial Intelligence Algorithm to Detect

Not yet recruiting
  • Cardiac Disease
  • Ventricular Arrythmia
    • Paris, France
      Centre d'Investigation Clinique Paris-Est/Hôpital Pitié-Salpêtri
    Apr 13, 2023

    Inherited Cardiac Arrythmias, Long QT Syndrome (LQTS), Brugada Syndrome (BrS) Trial in Baltimore

    Enrolling by invitation
    • Inherited Cardiac Arrythmias
    • +9 more
      • Baltimore, Maryland
        Johns Hopkins Medical Institute
      Jan 5, 2023

      Abnormalities, Cardiovascular Trial in Dallas (Volanesorsen, Moxifloxacin, Placebo)

      Completed
      • Abnormalities, Cardiovascular
      • Dallas, Texas
        Covance
      Jan 13, 2022

      Sudden Cardiac Death, Prolonged QTc Interval Trial in Los Angeles (EC with nicotine, EC without nicotine, control)

      Recruiting
      • Sudden Cardiac Death
      • Prolonged QTc Interval
      • EC with nicotine
      • +4 more
      • Los Angeles, California
        UCaliforniaLA
      Dec 3, 2021

      Hyperuricemia, Gout, Qt Interval, Variation in Trial in Austin (LC350189 200mg, Placebo, Moxifloxacin 400mg)

      Completed
      • Hyperuricemia
      • +2 more
      • LC350189 200mg
      • +3 more
      • Austin, Texas
        PPD
      Dec 15, 2021

      HEmiplegia Arrhythmia Retrospective Trial

      Recruiting
      • Alternating Hemiplegia of Childhood
      • Recording of clinical parameters and electrocardiogram parameters
      • Bron, France
        Department of Clinical Epileptology, Sleep Disorders and Functio
      Jun 21, 2021

      Healthy Trial in Brussels (Sertraline, Moxifloxacin, Drug - Placebo)

      Completed
      • Healthy
      • Brussels, Belgium
        Pfizer Clinical Research Unit
      Jan 25, 2021

      Healthy Subjects Trial in New Haven (Venlafaxine, Moxifloxacin, Drug - )

      Completed
      • Healthy Subjects
      • New Haven, Connecticut
        Pfizer New Haven Clinical Research Unit
      Jan 26, 2021

      Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Tempe (Ampreloxetine <Dose A>, Ampreloxetine <Dose B>,

      Completed
      • Symptomatic Neurogenic Orthostatic Hypertension
      • nOH
      • Ampreloxetine <Dose A>
      • +4 more
      • Tempe, Arizona
        Theravance Biopharma Investigational Site
      Apr 19, 2021

      Cardiovascular Disease, Pulmonary Arterial Hypertension, Heart Failure Trial in Leeds (BIA 5-1058, Placebo Oral Tablet,

      Completed
      • Cardiovascular Disease
      • +2 more
      • BIA 5-1058
      • +2 more
      • Leeds, United Kingdom
        Covance Clinical Research Unit Ltd.
      Dec 30, 2020

      Restless Legs Syndrome Trial in Austin (GEn 1200mg, Gen 6000 mg, GEn Placebo)

      Completed
      • Restless Legs Syndrome
      • GEn 1200mg
      • +4 more
      • Austin, Texas
        GSK Investigational Site
      Apr 7, 2021

      Cardiac Arrythmias Trial in Vancouver (Carbetocin)

      Completed
      Has Results
      • Cardiac Arrythmias
      • Vancouver, British Columbia, Canada
        BC Women's Hospital
      Apr 22, 2021

      Prolonged QTc Interval, Pharmacokinetic Trial in West Bend (100 µg cebranopadol, 200 µg cebranopadol, 400 µg cebranopadol)

      Completed
      • Prolonged QTc Interval
      • Pharmacokinetic
      • 100 μg cebranopadol
      • +5 more
      • West Bend, Wisconsin
        US001 Contract research organization
      Jul 13, 2021

      Healthy Trial in Austin (ALXN1840, Placebo, Moxifloxacin)

      Unknown status
      • Healthy
      • Austin, Texas
        Clinical Research Site
      Feb 11, 2021